How many insider trades does FilingIQ track for GMRS?

FilingIQ tracks 21 Form 4 insider transactions for GMRS (GMR Solutions Inc.), covering filings from Dec 12, 2025 onwards. 20 of those were filed in the last 90 days.

Are GMRS insiders net buyers or net sellers?

Across the full Form 4 history for GMRS, 1 transactions (5%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GMRS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GMRS in?

GMR Solutions Inc. (GMRS) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $588.73M.

GMRS insider trading

NYSE Healthcare

GMR Solutions Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

5% / 0%

Market cap

$588.73M

About GMR Solutions Inc.

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.

Company website: globalmedicalresponse.com

GMRS insider activity at a glance

FilingIQ has scored 21 insider transactions for GMRS since Dec 12, 2025. The most recent filing in our index is dated Jul 1, 2026.

Across the full history, 1 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GMRS insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GMRS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,099

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 232

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for GMRS?: FilingIQ tracks 21 Form 4 insider transactions for GMRS (GMR Solutions Inc.), covering filings from Dec 12, 2025 onwards. 20 of those were filed in the last 90 days.
Are GMRS insiders net buyers or net sellers?: Across the full Form 4 history for GMRS, 1 transactions (5%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GMRS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GMRS in?: GMR Solutions Inc. (GMRS) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $588.73M.

Methodology & sources

Every GMRS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.